Printer Friendly

CYTOPROBE CORP. NAMES NEW PRESIDENT

 SAN DIEGO, June 18 /PRNewswire/ -- CytoProbe Corp. (NASDAQ: CYTP) (the "company") today announced the election of John M. Zabsky to the office of president, succeeding Donald Hendrick who resigned for personal reasons. Zabsky has a masters of science in mechanical engineering from Kansas University and comes to CytoProbe via Amorphous Technologies International Inc., where he served as vice president. Zabsky specialized in engineering design in the fields of defense and aerospace, machinery and energy, as well as high technology controls and materials. His technical management position in the past gives Zabsky additional experience in applied research and development, strategic planning and product program execution to the marketplace.
 Hendrick remains with the company as senior consultant and advisor to the projects currently underway -- the Intracranial Pressure (ICP) measuring device and the Automated Endoscopic Cell Recovery device.
 CytoProbe Corp. operates two primary businesses: the development, manufacturing and marketing of specialty medical devices and the exploration, development and production of oil and gas reserves.
 -0- 6/18/93
 /CONTACT: CytoProbe Corp., 619-689-9400/
 (CYTP)


CO: CytoProbe Corp. ST: California IN: MTC OIL SU: PER

JB-MF -- SD002 -- 3450 06/18/93 09:15 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jun 18, 1993
Words:189
Previous Article:SUN DISTRIBUTORS L.P. ANNOUNCES CASH DISTRIBUTIONS
Next Article:UPTONS PLANS EXPANSION IN NASHVILLE, TENN.
Topics:


Related Articles
HAILEY ENERGY STOCKHOLDERS APPROVE NAME CHANGE TO CYTOPROBE CORP.
CYTOPROBE SUBSIDIARY ICP ENTERS INTO AGREEMENT WITH MEDYS
CYTOPROBE CORP. ANNOUNCES TEAMING AGREEMENT WITH SCIENTIFIC-ATLANTA INC.
CYTOPROBE ANNOUNCES APPROVAL TO BEGIN TESTING OF DEVICE
CYTOPROBE CORP. ANNOUNCES MEDICAL ADVISORY BOARD
CYTOPROBE CORP. TO BEGIN ICP CLINICAL TRIALS
CYTOPROBE CORPORATION ANNOUNCES REVERSE STOCK SPLIT
CYTOPROBE CORP. FACES COURT BATTLE
CYTOPROBE CORP. ANNOUNCES ADOPTION OF RIGHTS PLAN
CYTOPROBE CORPORATION ANNOUNCES APPOINTMENT OF LEE HULSEBUS AS CHAIRMAN OF THE BOARD

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters